About Us
Biographies & Photos
Current & Future Treatments
Image library
News
Medical Conferences
Links
Oncology
Virtual Press Room
Home
Contact Us
Sitemap
Search
Go
Please login
To view this content you have to login.
Username:
Password:
Forgotten your Password?
Click here to read our
disclaimer
.
I accept the terms and conditions
If you are a first time user, please
register here
.
LATEST NEWS
-----
GSK SHOWS PROMACTA
®
/REVOLADE
®
(ELTROMBOPAG) SIGNIFICANTLY INCREASED PLATELET COUNTS AND REDUCED BLEEDING IN LONG-TERM STUDY OF PATIENTS WITH CHRONIC ITP
-----
ARZERRA
TM
(OFATUMUMAB) DEMONSTRATES HIGH RESPONSE RATES IN PATIENTS WITH FLUDARABINE REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)
-----
Subscribe to our news alert service
© 2006 GlaxoSmithKline - All Rights Reserved.
|
Legal Notices
|
Privacy Statement
